Sonoma Pharmaceuticals (SNOA) Free Cash Flow: 2011-2025
Historic Free Cash Flow for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to -$168,000.
- Sonoma Pharmaceuticals' Free Cash Flow rose 25.38% to -$1.2 million in Q1 2013 from the same period last year, while for Mar 2013 it was $893,000, marking a year-over-year increase of 120.44%. This contributed to the annual value of -$168,000 for FY2025, which is 93.00% up from last year.
- Sonoma Pharmaceuticals' Free Cash Flow amounted to -$168,000 in FY2025, which was up 93.00% from -$2.4 million recorded in FY2024.
- In the past 5 years, Sonoma Pharmaceuticals' Free Cash Flow ranged from a high of -$168,000 in FY2025 and a low of -$6.4 million during FY2023.
- For the 3-year period, Sonoma Pharmaceuticals' Free Cash Flow averaged around -$3.0 million, with its median value being -$2.4 million (2024).
- In the last 5 years, Sonoma Pharmaceuticals' Free Cash Flow slumped by 46.43% in 2023 and then surged by 93.00% in 2025.
- Over the past 5 years, Sonoma Pharmaceuticals' Free Cash Flow (Yearly) stood at -$3.6 million in 2021, then fell by 23.28% to -$4.4 million in 2022, then plummeted by 46.43% to -$6.4 million in 2023, then spiked by 62.62% to -$2.4 million in 2024, then surged by 93.00% to -$168,000 in 2025.